Delivery Order SPE2DB22D3011-SPE2DB25FQ2UF
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 15, 2025, for the supply of Venofer 100 mg/5 mL vials with a ceiling value of $1,502.16 and firm fixed pricing. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was made without set-aside designation through competitive procurement,...
- The Defense Logistics Agency awarded a delivery order valued at $2,222.42 to AmerisourceBergen Drug Corp for the supply of Venofer 100 mg/5 mL vials on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price contract was competitively awarded without set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $8,440.81 to AmerisourceBergen Drug Corp for the supply of Venofer 100 mg/5 mL vials. This competitively awarded, firm fixed-price contract was issued on September 18, 2025, with an ultimate completion date of September 19, 2025. The product will be performed and delivered from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $4,929.73 to AmerisourceBergen Drug Corp for Venofer 100 mg/5 ml vials, with an ultimate completion date of July 24, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating open competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on June 20, 2025, for Venofer (iron sucrose) 100 mg/5 ml vials with a ceiling value of $2,454.96 and an ultimate completion date of June 23, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award based on merit. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued...
- The Defense Logistics Agency awarded a delivery order valued at $2,154.32 to AmerisourceBergen Drug Corp for the supply of Venofer 100 mg/5 mL vials on August 27, 2025, with completion scheduled for August 28, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location in the same...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a for-profit organization and leading global pharmaceutical distributor. The contract, valued at $3,927.61, is for the supply of 4,563,667,614 units of the medication Venofer 100 mg/5 ml vial with a 5 ml size. The contract does not have a set-aside designation. In addition to this specific delivery order, AmerisourceBergen Drug Corp holds an indefinite delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation. The $4,439.86 firm fixed-price contract is for the supply of 100 mg/5 ml Venofer vials, a prescription iron supplement medication. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. This...
- This contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is for the delivery of Venofer 100 mg/5 ml vials, a pharmaceutical product used in the treatment of iron deficiency anemia. The $3,119.19 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a major defense agency that provides medical supplies and equipment to military treatment facilities. This award is part of a larger Indefinite Delivery Contract (IDC)...
- The U.S. Defense Logistics Agency (DLA) has awarded a delivery order contract to Amerisourcebergen Drug Corp, Corporate Office Division, for the supply of Venofer 100 mg/5 ml vials. The firm-fixed-price contract, valued at $2,306.21, has a completion date of July 15, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC...
- SPE2DB22D3011Indefinite Delivery Contract
- SPE2DB22D3011-SPE2DB25FQ2UFDelivery Order
The Defense Logistics Agency awarded a $4,904.63 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Venofer (iron sucrose) 200 mg/10 ml vials. This non-competitive delivery order, issued on September 17, 2025, with an ultimate completion date of September 18, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Venofer is an intravenous iron replacement therapy used primarily in the treatment of iron deficiency anemia in patients with chronic kidney disease, making it a critical pharmaceutical product for military and veteran healthcare systems. This delivery order represents a child contract under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime pharmaceutical contract vehicle enables the contractor to supply a comprehensive range of medications and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated consistent capability in fulfilling federal medical procurement requirements through competitive awards and serves critical defense healthcare customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.9k | 9/17/25 |